Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by investclubon Sep 29, 2019 3:30pm
140 Views
Post# 30175460

RE:RE:RE:RE:RE:RE:So why hasn’t Mackie get the stock price up?

RE:RE:RE:RE:RE:RE:So why hasn’t Mackie get the stock price up?Yes you did Quattro74 and I wasn't sure if you were just being conservative in your estimate but now after reading your reply it's obvious we're thinking on the same lines. What really excites me is when Theralase starts into the PH1 trials for brain & lung however I think someone here mentioned they might be able to go directly into PH2 or am I mistaken in that?


Quattro74 wrote

Investclub, I did say 'or better'. TLT is a special case as it might take it a while longer to get on the nasdaq, that is where the other stock had been for a while, building value, before the big $17Bil offer came in. I think TLTs tech is way better than that other company. Yet we are a small Cad company that no one has heard of, PDT is off the radar still... I think a year after we have AA for NMIBC, and revenues are coming in, we should start to see some real interest.

Bullboard Posts